Aug 25 (Reuters) - The following bids, mergers,

acquisitions and disposals were reported by 1930 GMT on Monday:

** AbbVie ( ABBV ) will buy an experimental depression drug

from partner Gilgamesh Pharmaceuticals for up to $1.2 billion,

the companies said, seeking to access a fast-growing market for

psychedelic-based treatments.

** U.S. soft drinks giant Keurig Dr Pepper ( KDP ) is set to

create a global coffee giant to rival market leader Nestle

with an $18 billion takeover of JDE Peet's,

Europe's largest acquisition in more than two years.

** Thoma Bravo will acquire Verint Systems ( VRNT ) in a $2

billion deal, including debt, the customer engagement platform

said on Monday, marking the latest software buyout as private

equity firms increasingly bet on AI to navigate an uncertain

economy.

** U.S. shale producer Crescent Energy ( CRGY ) said it

would acquire smaller peer Vital Energy ( VTLE ) in an all-stock

deal valued at $3.1 billion, including debt.

** The pension trust of Mercedes-Benz will

sell off its roughly $346 million shareholding, a 3.8% stake, in

Nissan Motor ( NSANF ), a spokesperson for the German carmaker

said , adding to pressure on the Japanese automaker's share

price.

** Royalty Pharma ( RPRX ) said it has signed a deal

with BeOne Medicines to acquire a royalty interest in Amgen's ( AMGN )

drug for small cell lung cancer for up to $950 million.

** French cocoa trader Touton SA said it was in

exclusive talks to be sold to commodity and energy trader

Hartree Partners.

** Vienna Insurance Group (VIG) said it has won a public

auction to acquire 80% of leading Moldovan non-life insurer

Moldasig SA, strengthening its position in Central and Eastern

Europe (CEE).

** The owners of the EPIC Crude pipeline are exploring a

sale, with any deal likely to value the energy infrastructure at

around $3 billion including debt, people familiar with the

matter said.

(Compiled by Rajarshi Roy and Pooja Menon in Bengaluru)